Darden (DRI) Director Reports 21,943-Share Sale and 886 RSU Grant
Rhea-AI Filing Summary
Charles M. Sonsteby, a director of Darden Restaurants (DRI), reported changes in his holdings on a Form 4 filed for transactions dated September 17, 2025. The filing shows a disposal of 21,943 shares of Common Stock and the grant/acquisition of 886 Restricted Stock Units (RSUs) tied to the FY26 director annual grant. The RSUs convert one-for-one into common shares, vest the earlier of one year from grant or the next annual shareholder meeting, and include a one-time option to defer settlement until the director leaves the board. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person.
Positive
- Receipt of 886 RSUs as FY26 director annual grant with standard one-for-one conversion to common stock
- RSU vesting terms include a deferral option until termination from the board, providing flexibility
Negative
- Disposal of 21,943 common shares by a company director reported on 09/17/2025
Insights
TL;DR: A director sold 21,943 shares and received 886 RSUs with standard vesting and deferral rights.
The disposal of 21,943 common shares is a straightforward non-derivative sale recorded on the Form 4, while the RSU grant of 886 units is a routine director compensation element. The RSUs vest on customary triggers: one year or the next annual meeting, and include a deferral option until board departure, which is typical for independent director equity awards. No unusual acceleration, performance conditions, or derivative exercises are disclosed.
TL;DR: Insider reported both a sale and a standard director equity grant; impact appears neutral.
The filing combines a disposal of common stock with the acquisition of restricted stock units granted as FY26 director compensation. The RSUs convert one-for-one to common shares with a $0.00 per-share price reported, indicating standard grant accounting rather than purchase. The size of the RSU grant (886 shares) is modest relative to typical institutional positions and there are no derivative instruments retained. From a disclosure standpoint the Form 4 provides clear transaction dates and vesting mechanics.